StocksRunner logo
mail
search
 
menu
 
Laboratory Corporati
$264.96
-1.05%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
 
 

LH

 

Laboratory Corporati

$264.96

 
-$2.73 | -1.05%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 283.47
 
 
MKT CAP
$ 22.18B
 
52W Low
$ 209.38
 
 
VOL
$ 838.36K
 
P/E Ratio
29.21
 
 
AVG VOL
$ 809.58K
 
RSI
62.32
 
 
TREND
Sideways
 
 
 

Chart

 
 

$247.85   (+6.90%)

$216.98   (+22.11%)

$253.03   (+4.71%)

$233.39   (+13.53%)

 
 
1year
6month
3month
1month
 
LH Latest Analysis +
 
 
 
StocksRunner

Explore our LH Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored LH Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our LH Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Earnings
mail
 
 

LH

 

Laboratory Corporati

 
 

Current Price

 

$264.96

 
-$2.73 | -1.05%
 
LH Rating Score

Hold

 
52W High
$ 283.47
 
 
MKT CAP
$ 22.18B
 
52W Low
$ 209.38
 
 
VOL
$ 838.36K
 
P/E Ratio
29.21
 
 
AVG VOL
$ 809.58K
 
RSI
62.32
 
 
TREND
Sideways
 
 
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 
 
 

LH Stock Rating

 
lock  Login to view Laboratory Corporati (LH) recommendation from the last 90 days from financial news and social media.
 

Chart

 
 

$247.85   (+6.90%)

$216.98   (+22.11%)

$253.03   (+4.71%)

$233.39   (+13.53%)

 
 
1year
6month
3month
1month
 
 
 
 
 

LH Latest Analysis

 
 
 

Matrix Medical Network Announces Strategic Partnership with Molecular Testing Labs to Enhance In-Home Diagnostic Offerings. Leader In Delivering Home-Based Health and Care Services Partners with Laboratory Known for Quality Reliability and Innovation NASHVILLE Tenn. July 23 2025 /PRNewswire/ -- Matrix Medical Network (Matrix) a leader in delivering high quality home-based health and care services...

 

Today

$264.96 | -1.05%
 
Activity
Potential

Engaging In Options Activity Cornelius P. McCarthy III Exercises Options Valued At $740K In Medpace Hldgs. Highlighted on July 24 it was unveiled in an SEC filing that III Director at ) executed a significant transaction involving the exercise of company stock options.United States Securities and Exchange Commission III Director at Medpace Hldgs executed a strategic derivative sale. This involved exercising stock options for 1972 shares of MEDP resulting in a transaction value of $740111.As of F

 

Today

$264.96 | -1.05%
 
Activity

Witnessing An Insider Decision Cornelius P. McCarthy III Exercises Options Valued At $1.85M At Medpace Hldgs. In a new SEC filing on July 22 it was revealed that III Board Member at ) executed a significant exercise of company stock options.United States Securities and Exchange Commission revealed that III Board Member at Medpace Hldgs exercised stock options for 4500 shares of MEDP resulting in a transaction value of $1854045.During Wednesday'.s morning session Medpace is a late-stage contr

 

Wed Jul 23, 2025

$250.51 | -0.62%
 
Activity
Activity

Epicore Biosystems Secures $1.2M AFWERX Phase II Contract to Enhance Military Hydration Readiness. Award will help accelerate deployment of Epicore'.s Connected Hydration®. platform to support Air Force operations and training (Epicore) announces it has been selected by AFWERX the innovation arm of the Department of Air Force for an SBIR Phase II in the amount of 1 wearable platform to address the personalized hydration management and recovery needs of personnel in the Department of the A

 

Wed Jul 23, 2025

$250.51 | -0.62%
 
Activity
Potential

A Glimpse of Laboratory Corps Earnings Potential. Laboratory Corp (NYSE:) is preparing to release its quarterly earnings on Thursday 2025-07-24. Here'.s a brief overview of what investors should keep in mind before the announcement.Analysts expect Laboratory Corp to report an Investors in Laboratory Corp are eagerly awaiting the company'.s announcement hoping for news of surpassing estimates and positive guidance for the next quarter.It'.s worth noting for new investors that stock pr

 

Wed Jul 23, 2025

$250.51 | -0.62%
 
Earnings

Matrix Medical Network Announces Strategic Partnership with Molecular Testing Labs to Enhance In-Home Diagnostic Offerings. Leader In Delivering Home-Based Health and Care Services Partners with Laboratory Known for Quality Reliability and Innovation NASHVILLE Tenn. July 23 2025 /PRNewswire/ -- Matrix Medical Network (Matrix) a leader in delivering high quality home-based health and care services...

 

Wed Jul 23, 2025

$250.51 | -0.62%
 
Activity
Potential

BD Board Declares Dividend. ) a leading global medical technology company today announced it has declared a quarterly dividend of About BDBD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology services and solutions that help advance both clinical therapy for patients and c

 

Tue Jul 22, 2025

$252.07 | +3.72%
 
Activity

[Latest] Global Plant Tissue Culture Market Size/Share Worth USD 1205.94 Million by 2034 at a 8.67% CAGR: Custom Market Insights (Analysis Outlook Leaders Report Trends Forecast Segmentation Growth Rate Value SWOT Analysis). Plant Tissue Culture Market Size Trends and Insights By Crop Type (Banana Plants Floriculture Plants Wood Producing Plants Fruit Plants Vegetable Plants Ornamental Plants Aquatic Plants Others) By Stage (Explant preparation and Inoculation Multiplication Hardening) By Plant

 

Tue Jul 22, 2025

$252.07 | +3.72%
 
Activity
Potential

AEMD: No SAEs in Cohort 1 Post-Hemopurifier Treatment. Progressing Trial to Cohort 2. By Data Safety Monitoring Board Recommends Progressing Trial Without ModificationAethlon Medicals (NASDAQ:AEMD) current primary focus is on researching lead asset the Hemopurifier® therapeutic blood filtration system as a potential treatment in oncology. AEMD is conducting a basket oncology trial[1] to study the impact of the Hemopurifier in patients with various solid tumors who have stable or progressive dise

 

Thu Jul 17, 2025

$247.24 | +0.52%
 
Potential

Diverging Treatment Goals Emerge Between Hematologists and Nephrologists in aHUS Care According to Spherix Global Insights. EXTON PA July 17 2025 (GLOBE NEWSWIRE) -- In the latest Special Topix™.: Co-Management Approaches in aHUS (US) Spherix Global Insights explores the nuanced dynamics between hematologists and nephrologists in the management of atypical hemolytic uremic syndrome (aHUS). Based on a quantitative survey of 103 specialists conducted between May and June 2025 the research re

 

Thu Jul 17, 2025

$247.24 | +0.52%
 
Activity
Potential

 
 
 
 
 
StocksRunner

Discover LH Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of LH. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our LH Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

LH Stock trends

LH Stock performance

LH Stock analysis

LH investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

UnAlert LH Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 

 
 
Post ×
 
0/666
joker
 
 
 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing LH

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing LH

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.